MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- Neodyne Biosciences announced a new size device today that is designed to significantly minimize scarring for surgical incisions and lacerations that are 1.5 inches or smaller in length. As adoption continues to grow, the company introduces the newest size of embrace® Active Scar Defense, the only preventative scar device that is clinically proven to treat the root cause of scarring.
Unlike messy creams, oily gels, and static silicone gel sheeting, the embrace device - which features Stress-Shield™ Technology - is uniquely effective at mechanically shielding the incision area from tension to significantly improve the appearance and texture of scars and to reduce their overall size.
"The successful results we see using embrace after plastic and general surgery procedures, led to significant demand for a device to treat smaller, closed incision sites," said Kelley Lipman, Chief Commercial Officer of Neodyne. "These incisions are usually located in a highly visible area and benefit greatly from the dramatic improvement in overall appearance yielded by the wear of embrace."
Cuts and lacerations that require stitches can be susceptible to scarring and research shows that wounds turn to scars when they're subjected to a high-tension environment. Fortunately, clinical evidence supports that embrace creates a low-tension environment which helps to prevent scarring before it even starts.
"We've been using the existing sizes of embrace to defy scarring in our patients for several years now," said, Payman Danielpour, MD of Beverly Hills Plastic Surgery Group. "It's been nice to offer a scar minimizing device to our patients, and we're excited to offer this new size for smaller scar revision procedures, mole removals, pediatric facial lacerations and other incisions in challenging anatomical locations."
embrace is currently available for purchase from many plastic surgery offices. To find out where you can find embrace, visit Neodyne at www.embracescartherapy.com or call 1-855-722-7879.
About Neodyne Biosciences, Inc.
Neodyne Biosciences (www.neodynebio.com) is an evidence based company developing and commercializing innovative tissue repair devices to minimize scar formation, restoring both function and aesthetic appearance. The company is developing stress-shielding devices capable of controlling the mechanical wound environment to ameliorate post-surgical scarring. Although the etiology remains unclear, mechanical forces such as surrounding skin tension and body movement have been demonstrated to increase fibrosis and scar formation. It is estimated that approximately 80 million major surgical procedures are performed in the United States each year and 230 million performed worldwide. Patient frustration with post-surgical scarring spans a variety of procedures with many seeking means of prevention and treatment.
Neodyne Investor Relations Contacts:
SOURCE Neodyne Biosciences, Inc.